Overcoming Chemoresistance via an AIEgen-Based Covalent Organic Framework
Nano Letters · 11.02.2026 · 26 (5) · 1662-1672
DOI: 10.1021/acs.nanolett.5c05157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 02.02.2026. Verfasst von An Song und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Metal-Organic Frameworks, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Interdisciplinary Innovative Foundation of Wuhan University, National Key Basic Research Program of China.
Abstract (Originalsprache)
Chemoresistance remains a major barrier to effective cancer treatment, leading to tumor recurrence and high mortality. Developing strategies to combat chemoresistant tumors is therefore an urgent challenge. Here, we report a covalent organic framework (COF) nanomedicine, 3N-DPQ-COF, designed to target chemoresistant cancers. Mechanistic studies reveal that 3N-DPQ-COF accumulates efficiently in resistant tumor cells and suppresses cancer stemness in 4T1 and CT26 models, outperforming doxorubicin. Moreover, 3N-DPQ-COF promotes CD8 + T-cell infiltration and reduces the number of immunosuppressive erythroid progenitor cells and myeloid-derived suppressor cells, thereby remodeling the tumor microenvironment (TME) and inducing GSDME-dependent pyroptosis. Remarkably, even without checkpoint blockade, 3N-DPQ-COF suppresses metastasis and recurrence in chemoresistant 4T1 tumors, achieving >90% tumor inhibition and cure rates exceeding 80%. This study highlights the potential of AIEgen-based COF nanomedicines for overcoming chemoresistance through concurrent modulation of tumor stemness, pyroptosis, and immune activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Sci…
- Department of Oral and Maxillofacial Surgery, The Affiliated Stomatological Hospital, State Key Laboratory Cultivation Base of Research, Prevention and Treatment of Oral Diseases, Jiangsu Province Engineering Research C…
- State Key Laboratory of Precision and Intelligent Chemistry, School of Chemistry and Materials Science, University of Science and Technology of China, Hefei 230000, China.
ORCID-Profile: Xiao-Long Zhang, Wu-Yin Wang, Tian-Fu Wu, Zhi-Jun Sun
Förderung
- National Natural Science Foundation of China
- Interdisciplinary Innovative Foundation of Wuhan University
- National Key Basic Research Program of China
- Innovation Team of Wuhan University
- robotic AI-Scientist platform of the Chinese Academy of Science, and the USTC startup fund
- National Key Research and Development Program of China
- Wuhan University
- the robotic AI-Scientist platform of the Chinese Academy of Science, and the USTC startup fund
Zitieren
APA
Song, A., Wang, Q., Liu, B. Y., Yang, Q. C., Hu, Z. Y., Lei, H. T., Zhang, X. L., Gao, F. L., Wang, W. Y., Zhang, M. J., Wang, S., Wu, T. F., Zhang, L., & Sun, Z. J. (2026). Overcoming Chemoresistance via an AIEgen-Based Covalent Organic Framework. Nano Letters, 26(5), 1662-1672. https://doi.org/10.1021/acs.nanolett.5c05157
Vancouver
Song A, Wang Q, Liu BY, Yang QC, Hu ZY, Lei HT, et al. Overcoming Chemoresistance via an AIEgen-Based Covalent Organic Framework. Nano Letters. 2026;26(5):1662-1672. doi:10.1021/acs.nanolett.5c05157
BibTeX
@article{Song2026,
author = {Song, An and Wang, Qing and Liu, Bo-Yu and Yang, Qi-Chao and Hu, Zi-Yan and Lei, Heng-Tao and Zhang, Xiao-Long and Gao, Fang-Ling and Wang, Wu-Yin and Zhang, Meng-Jie and Wang, Shuo and Wu, Tian-Fu and Zhang, Liang and Sun, Zhi-Jun},
title = {Overcoming Chemoresistance via an AIEgen-Based Covalent Organic Framework},
journal = {Nano Letters},
year = {2026},
volume = {26},
number = {5},
pages = {1662--1672},
doi = {10.1021/acs.nanolett.5c05157}
}
EUVIMED